CLINICAL_TRIALS
trial_result
· 2020-11-24
Clinical Trial Update: A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer [Phase 2]
Summary
Phase 2a study of Modified Vaccinia Virus for sorafenib-naïve advanced hepatocellular carcinoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jennerex Biotherapeutics | Conditions: Hepatocellular Carinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-11-24